Neff AT - Search Results

1

Neff AT, Sidonio RF Jr. Neff AT, et al. Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):536-41. doi: 10.1182/asheducation-2014.1.536. Epub 2014 Nov 18. Hematology Am Soc Hematol Educ Program. 2014. PMID: 25696907 Review.

2

Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program.

Christopherson PA, Haberichter SL, Flood VH, Perry CL, Sadler BE, Bellissimo DB, Di Paola J, Montgomery RR; Zimmerman Program Investigators. Christopherson PA, et al. J Thromb Haemost. 2022 Jul;20(7):1576-1588. doi: 10.1111/jth.15713. Epub 2022 Apr 6. J Thromb Haemost. 2022. PMID: 35343054 Free article.

3

Laboratory variability in the diagnosis of type 2 VWD variants.

DiGiandomenico S, Christopherson PA, Haberichter SL, Abshire TC, Montgomery RR, Flood VH; Zimmerman Program Investigators. DiGiandomenico S, et al. J Thromb Haemost. 2021 Jan;19(1):131-138. doi: 10.1111/jth.15129. Epub 2020 Nov 10. J Thromb Haemost. 2021. PMID: 33049112 Free PMC article.

4

Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay.

Boylan B, Rice AS, Neff AT, Manco-Johnson MJ, Kempton CL, Miller CH; Hemophilia Inhibitor Research Study Investigators. Boylan B, et al. Among authors: neff at. J Thromb Haemost. 2016 Oct;14(10):1931-1940. doi: 10.1111/jth.13438. Epub 2016 Sep 17. J Thromb Haemost. 2016. PMID: 27501440 Free PMC article.

5

Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease.

Metjian AD, Wang C, Sood SL, Cuker A, Peterson SM, Soucie JM, Konkle BA; HTCN Study Investigators. Metjian AD, et al. Haemophilia. 2009 Jul;15(4):918-25. doi: 10.1111/j.1365-2516.2009.02025.x. Epub 2009 Apr 7. Haemophilia. 2009. PMID: 19473418

6

Acquired factor V deficiency in a patient without evidence of a classical inhibitor.

Sosa IR, Ellery P, Mast A, Neff AT, Gailani D. Sosa IR, et al. Among authors: neff at. Haemophilia. 2014 Jan;20(1):e81-3. doi: 10.1111/hae.12280. Epub 2013 Oct 14. Haemophilia. 2014. PMID: 24118596 Free PMC article. No abstract available.

7

Current controversies in the diagnosis and management of von Willebrand disease.

Neff AT. Neff AT. Ther Adv Hematol. 2015 Aug;6(4):209-16. doi: 10.1177/2040620715587879. Ther Adv Hematol. 2015. PMID: 26288715 Free PMC article. Review.

8

Crucial role for the VWF A1 domain in binding to type IV collagen.

Flood VH, Schlauderaff AC, Haberichter SL, Slobodianuk TL, Jacobi PM, Bellissimo DB, Christopherson PA, Friedman KD, Gill JC, Hoffmann RG, Montgomery RR; Zimmerman Program Investigators. Flood VH, et al. Blood. 2015 Apr 2;125(14):2297-304. doi: 10.1182/blood-2014-11-610824. Epub 2015 Feb 6. Blood. 2015. PMID: 25662333 Free PMC article.

9

First report on the safety and efficacy of an extended half-life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia A.

Hampton K, Chowdary P, Dunkley S, Ehrenforth S, Jacobsen L, Neff A, Santagostino E, Sathar J, Takedani H, Takemoto CM, Négrier C. Hampton K, et al. Haemophilia. 2017 Sep;23(5):689-696. doi: 10.1111/hae.13246. Epub 2017 May 4. Haemophilia. 2017. PMID: 28470862

10

Feasibility of the Von Willebrand disease PREVENT trial.

Ragni MV, Machin N, James AH, Seaman CD, Malec LM, Kessler CM, Konkle BA, Kouides PA, Neff AT, Philipp CS, Brooks MM. Ragni MV, et al. Among authors: neff at. Thromb Res. 2017 Aug;156:8-13. doi: 10.1016/j.thromres.2017.05.022. Epub 2017 May 25. Thromb Res. 2017. PMID: 28577390

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page